Part 250 Special Requirements for Specific Human Drugs

Subpart A - Drugs Regarded as Misbranded

• § 250.11   Thyroid-containing drug preparations intended for treatment of obesity in humans
• § 250.12   Stramonium preparations labeled with directions for use in self-medication regarded as misbranded

Subpart B - New Drug or Prescription Status of Specific Drugs

• § 250.100   Amyl nitrite inhalant as a prescription drug for human use
• § 250.101   Amphetamine and methamphetamine inhalers regarded as prescription drugs
• § 250.102   Drug preparations intended for human use containing certain “coronary vasodilators”
• § 250.105   Gelsemium-containing preparations regarded as prescription drugs
• § 250.108   Potassium permanganate preparations as prescription drugs

Subpart C - Requirements for Drugs and Foods

• § 250.201   Preparations for the treatment of pernicious anemia

Subpart D - Requirements for Drugs and Cosmetics

• § 250.250   Hexachlorophene, as a component of drug and cosmetic products